C151H197N39O14S3 — CID 160545579
N-[4-(azetidin-1-ylmethyl)-2-methylphenyl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;bis(6-[cyclohexyl(2-methylpropyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide);6-[cyclohexyl(propyl)amino]-N-(1H-indazol-5-yl)pyrimidine-4-carboxamide;6-[cyclopentyl(2-methoxyethyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(imidazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(1,2,4-triazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide (PubChem CID 160545579) has the molecular formula C151H197N39O14S3 and a molecular weight of 2878.70 g/mol. Its IUPAC name is N-[4-(azetidin-1-ylmethyl)-2-methylphenyl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;bis(6-[cyclohexyl(2-methylpropyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide);6-[cyclohexyl(propyl)amino]-N-(1H-indazol-5-yl)pyrimidine-4-carboxamide;6-[cyclopentyl(2-methoxyethyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(imidazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(1,2,4-triazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide.
| Compound Name | N-[4-(azetidin-1-ylmethyl)-2-methylphenyl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;bis(6-[cyclohexyl(2-methylpropyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide);6-[cyclohexyl(propyl)amino]-N-(1H-indazol-5-yl)pyrimidine-4-carboxamide;6-[cyclopentyl(2-methoxyethyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(imidazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(1,2,4-triazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 160545579 |
| Molecular Formula | C151H197N39O14S3 |
| Molecular Weight | 2878.70 g/mol |
| Exact Mass | 2876.51 |
| IUPAC Name | N-[4-(azetidin-1-ylmethyl)-2-methylphenyl]-6-[cyclopropylmethyl(propyl)amino]pyrimidine-4-carboxamide;bis(6-[cyclohexyl(2-methylpropyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide);6-[cyclohexyl(propyl)amino]-N-(1H-indazol-5-yl)pyrimidine-4-carboxamide;6-[cyclopentyl(2-methoxyethyl)amino]-N-(2-methyl-4-sulfamoylphenyl)pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(imidazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide;6-[cyclopropylmethyl(propyl)amino]-N-[3-(1,2,4-triazol-1-ylmethyl)phenyl]pyrimidine-4-carboxamide |
| SMILES | CCCN(CC1CC1)c1cc(C(=O)Nc2ccc(CN3CCC3)cc2C)ncn1.CCCN(CC1CC1)c1cc(C(=O)Nc2cccc(Cn3ccnc3)c2)ncn1.CCCN(CC1CC1)c1cc(C(=O)Nc2cccc(Cn3cncn3)c2)ncn1.CCCN(c1cc(C(=O)Nc2ccc3[nH]ncc3c2)ncn1)C1CCCCC1.COCCN(c1cc(C(=O)Nc2ccc(S(N)(=O)=O)cc2C)ncn1)C1CCCC1.Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC(C)C)C2CCCCC2)ncn1.Cc1cc(S(N)(=O)=O)ccc1NC(=O)c1cc(N(CC(C)C)C2CCCCC2)ncn1 |
| InChI | InChI=1S/C23H31N5O.C22H26N6O.2C22H31N5O3S.C21H25N7O.C21H26N6O.C20H27N5O4S/c1-3-9-28(15-18-5-6-18)22-13-21(24-16-25-22)23(29)26-20-8-7-19(12-17(20)2)14-27-10-4-11-27;1-2-9-28(14-17-6-7-17)21-12-20(24-15-25-21)22(29)26-19-5-3-4-18(11-19)13-27-10-8-23-16-27;2*1-15(2)13-27(17-7-5-4-6-8-17)21-12-20(24-14-25-21)22(28)26-19-10-9-18(11-16(19)3)31(23,29)30;1-2-8-27(11-16-6-7-16)20-10-19(23-14-24-20)21(29)26-18-5-3-4-17(9-18)12-28-15-22-13-25-28;1-2-10-27(17-6-4-3-5-7-17)20-12-19(22-14-23-20)21(28)25-16-8-9-18-15(11-16)13-24-26-18;1-14-11-16(30(21,27)28)7-8-17(14)24-20(26)18-12-19(23-13-22-18)25(9-10-29-2)15-5-3-4-6-15/h7-8,12-13,16,18H,3-6,9-11,14-15H2,1-2H3,(H,26,29);3-5,8,10-12,15-17H,2,6-7,9,13-14H2,1H3,(H,26,29);2*9-12,14-15,17H,4-8,13H2,1-3H3,(H,26,28)(H2,23,29,30);3-5,9-10,13-16H,2,6-8,11-12H2,1H3,(H,26,29);8-9,11-14,17H,2-7,10H2,1H3,(H,24,26)(H,25,28);7-8,11-13,15H,3-6,9-10H2,1-2H3,(H,24,26)(H2,21,27,28) |
| InChIKey | QXJQNONJBWIFIE-UHFFFAOYSA-N |
| XLogP | 23.66 |
| TPSA | 677.00 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 42 |
| Rotatable Bonds | 55 |
| Heavy Atoms | 207 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2878.70 |
| LogP ≤ 5 | 23.66 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 42 |